CIBC Bancorp USA’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.6M Sell
1,109,342
-365,959
-25% -$9.7M 0.04% 326
2026
Q2
$35.5M Sell
1,475,301
-295,662
-17% -$7.73M 0.04% 306
2026
Q1
$49.7M Buy
+1,770,963
New +$47.1M 0.07% 223
2025
Q3
$20.1M Buy
+787,505
New +$19.4M 0.11% 153

Other funds holding PFE

CIBC Bancorp USA's PFE Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Pfizer (PFE) stake by 25% in Q3 2026, selling an estimated $9.7M and leaving 1,109,342 shares worth $31.6M. The position accounts for 0.04% of the portfolio, ranked #326.

CIBC Bancorp USA first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $49.7M in Q1 2026. 2,888 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • CIBC Bancorp USA held 1,109,342 shares of Pfizer worth $31.6M as of Q3 2026.
  • CIBC Bancorp USA sold 365,959 Pfizer shares in Q3 2026, an estimated $9.7M.
  • Pfizer made up 0.04% of CIBC Bancorp USA's portfolio in Q3 2026, its #326 holding.
  • CIBC Bancorp USA first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Pfizer position peaked at $49.7M in Q1 2026.
  • 2,888 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.